510(k) device
Brainsway Deep (DTMS) System
Brainsway , Ltd. · Transcranial Magnetic Stimulator (OBP, Class II) · First FDA decision May 3, 2018, newest May 3, 2018DepressionOCD, PTSD and other psychiatric conditions
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
41
Naming "Brainsway Deep"
MAUDE reports
4
Brand "Brainsway Deep", since 2015
PubMed studies
0
Mentioning "Brainsway Deep"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Brainsway Deep (DTMS) System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K173540 · Decided May 3, 2018 · 169 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcranial Magnetic StimulationLocal determinationIn effectL33398Wellpoint FederalUpdated Jul 16, 2026
- Transcranial Magnetic StimulationProposed local determinationProposedDL33398National Government Services, Inc.Updated Mar 27, 2026
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL34641WPS Insurance CorporationUpdated Mar 20, 2026
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL37086Noridian Healthcare Solutions, LLCUpdated Aug 6, 2025
- Repetitive Transcranial Magnetic Stimulation (rTMS) in AdultsLocal determinationIn effectL34869Palmetto GBAUpdated Jan 7, 2025
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL36469CGS Administrators, LLCUpdated May 30, 2024
- Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive DisorderLocal determinationIn effectL34522First Coast Service Options, Inc.Updated Oct 21, 2022
- Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive DisorderLocal determinationIn effectL34998Novitas Solutions, Inc.Updated Oct 21, 2022
Clinical trials
Device studies on ClinicalTrials.gov that name "Brainsway Deep", any status and sponsor, newest update first.
- Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD)Pivotal-lookingRecruiting
BrainswayNot on our public-company list
NCT07216872 · 186 participants (planned) · Start Nov 7, 2025 · Primary completion Nov 1, 2027
Device: Deep TMS (DTMS); Sham (No Treatment) · For: Alcohol Use Disorder; Alcoholism; Alcohol Abuse and 3 more
Sites: Tuscaloosa, Alabama; La Jolla, California; West Palm Beach, Florida · 11 sites in all
- COMpulsive Gambling: Efficacy of DEEP Transcranial Magnetic Stimulation With H7 COILNot yet recruiting
Sveti Ivan Psychiatric HospitalAcademic, hospital or other
NCT07828782 · 60 participants (planned) · Start Oct 2026 · Primary completion Apr 2027
Device: active r-TMS; Sham (No Treatment) · For: Gambling Disorder
- Deep Transcranial Magnetic Stimulation for Tobacco Cessation in Adults With Opioid Use DisorderNot yet recruiting
Payel RoyAcademic, hospital or other
NCT07770555 · 12 participants (planned) · Start Jan 2027 · Primary completion Dec 2027
Device: Deep TMS System With H4 Coil · For: Opioid Use Disorder; Tobacco Use Disorder
Sites: Pittsburgh, Pennsylvania · 2 sites in all
38 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Brainsway Deep", and for the whole product code for context.
This brand
4 reports: 0 malfunction, 4 injury, 0 death
Whole product code OBP
337 reports: 9 malfunction, 323 injury, 2 death
Newest reports for this brand
3010300912-2025-19110 · Received Jun 10, 2025 · Event dated May 2, 2025
Device type: Transcranial Magnetic Stimulator (OBP)
Device problem as coded: Improper or Incorrect Procedure or Method
Patient problem as coded: Convulsion/Seizure
MW5105345 · Received Nov 15, 2021 · Event dated Nov 5, 2021
Device type: Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder (QCI)
Device problem as coded: Patient-Device Incompatibility
Patient problem as coded: Memory Loss/Impairment; Nausea; Anxiety; Cognitive Changes; Confusion/ Disorientation
MW5084658 · Received Mar 5, 2019 · Event dated Feb 12, 2019
Device type: Transcranial Magnetic Stimulator (OBP)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Pulmonary Embolism; Erythema; Pain; Swelling; Thrombosis
1 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Brainsway Deep"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code OBP.
- NeuroStar TMS Therapy SystemNeuronetics, Inc. · 510(k) 2022
- BrainsWay Deep TMS SystemBrainsway , Ltd. · 510(k) 2025
- Apollo TMS Therapy SystemMag & More GmbH · 510(k) 2026
- MagVita TMS Therapy w/MagPro R20Tonica Elektronik A/S · 510(k) 2017
- NeuroStar Advanced Therapy System (All previously cleared models)Neuronetics, Inc. · 510(k) 2024
- Magstim Horizon 3.0 TMS Therapy SystemMagstim Company, Ltd. · 510(k) 2023
- HORIZON TMS Therapy System with NavigationMagstim Company, Ltd. · 510(k) 2019
- Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)Nexstim Oyj · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.